Studies on the teratogen pharmacophore of valproic acid analogues: evidence of interactions at a hydrophobic centre
- 1 August 1998
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 354 (2-3) , 289-299
- https://doi.org/10.1016/s0014-2999(98)00462-2
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Cell proliferation, migration and CAM-dependent neurite outgrowth as developmental in vitro endpoints for screening teratogenic potential: Application to valproic acid and related analogues of varying potencyToxicology in Vitro, 1998
- Valproic acid suppresses G1 phase‐dependent sialylation of a 65 kDa glycoprotein in the C6glioma cell cycleInternational Journal of Developmental Neuroscience, 1997
- Teratogenic potency of valproate analogues evaluated by quantitative estimation of cellular morphology in vitroToxicology in Vitro, 1996
- Effects of valproic acid on β-adrenergic receptors, G-proteins, and adenylyl cyclase in rat C6 glioma cellsNeuropsychopharmacology, 1996
- Antitumor activity of sodium valproate in cultures of human neuroblastoma cellsAnti-Cancer Drugs, 1996
- Further Branching of Valproate-Related Carboxylic Acids Reduces the Teratogenic Activity, but Not the Anticonvulsant EffectChemical Research in Toxicology, 1996
- Chronic Sodium Valproate Selectively Decreases Protein Kinase C α and ε In VitroJournal of Neurochemistry, 1994
- Clusters of neural cell adhesion molecule at sites of cell-cell contact.The Journal of cell biology, 1992
- Neurite outgrowth on muscle cell surfaces involves extracellular matrix receptors as well as Ca2+-dependent and -independent cell adhesion molecules.Proceedings of the National Academy of Sciences, 1987
- Quantitative correspondence between the in vivo and in vitro activity of teratogenic agents.Proceedings of the National Academy of Sciences, 1982